KI recently signed a frame agreement with Testa Center in Uppsala to enable access to laboratories for the scale up of biological products from lab bench to industrial-scale quantities.
Testa Center is an initiative between the Swedish government and Cytiva (formerly GE Healthcare Life Sciences) that offers businesses and academia nationwide a modern, pilot-scale testbed for projects and education in the production of biological products (up to Bio-safety level 2 and 500 liter).
The initial two-year frame agreement (with the potential for 2 one-year renewals) is effective as of September 1st 2021 and facilitates access for KI researchers to Testa Center industry quality laboratories and expertise for non-GMP large-scale cell culture, and production and purification of biological materials such as monoclonal antibodies, peptides, protein, vaccines, and viral vectors. As such, this agreement provides a good complement to the services provided by the Protein Science Facility at KI.
For more information about how to access the Testa Centre facility under this agreement please contact Tomas Nyman at PSF.